Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

VWF and FVIII Levels after Desmopressin Are Associated with the Bleeding Phenotype in Type 1 VWD

Ferdows Atiq, Lisette M. Schütte, MD, Agnes E.M. Looijen, Bsc, Johan Boender, MD, Moniek P.M. de Maat, PhD, Marieke J.H.A. Kruip, MD PhD, Frank W.G. Leebeek, MD PhD

Blood (2019) 134 (Supplement_1): 1116.

https://doi.org/10.1182/blood-2019-123634

Published: 2019

Journal Articles

Association of Obesity on Laboratory Profiles of Individuals with Type 1 Von Willebrand Disease and Low VWF in the Athn Dataset

Beverly Schaefer, MD, Dunlei Cheng, PhD, Peter A. Kouides, MD

Blood (2019) 134 (Supplement_1): 2415.

https://doi.org/10.1182/blood-2019-123781

Published: 2019

Journal Articles

Practice Patterns for Diagnosis of Type 1 Von Willebrand Disease and Effect of Age on Von Willebrand Factor Levels: A Single Institutional Retrospective Study

Meera Sridharan, MD, Sandra Heisler, L.P.N, Jansen Seheult, MD MB, BC, BAO, William L. Nichols, MD, Rajiv K. Pruthi, M.B.B.S.

Blood (2018) 132 (Supplement 1): 1183.

https://doi.org/10.1182/blood-2018-99-119137

Published: 2018

Journal Articles

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Mario von Depka, MD PhD, Mahnaz Ekhlasi-Hundrieser, Carsten Detering, MSc, Stefanie Lehner, Christiane Pfarrer, Hanna Allerkamp

Blood (2018) 132 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2018-99-112085

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

Feasibility of a Smartphone Application (App) Pictorial Blood Assessment Chart (PBAC) As an Endpoint in a Von Willebrand Disease Trial

Shawn Tahata, BS, BA, Margaret V. Ragni, MD MPH, Judith Kadosh, BSN RN

Blood (2017) 130 (Supplement 1): 3684.

https://doi.org/10.1182/blood.V130.Suppl_1.3684.3684

Published: 2017

Journal Articles

Differentiation of Patients with Type 1 Von Willebrand Disease Vs. Low Normal Levels of the Von Willebrand Factor Using a Very High Shear Rate, Non-Citrated Blood Flow System

Eric F. Grabowski, MD DSc, Elizabeth M. Van Cott, Larissa Bornikova, MD, Daniel Boyle, BA, Matthew Gerace

Blood (2017) 130 (Supplement 1): 2338.

https://doi.org/10.1182/blood.V130.Suppl_1.2338.2338

Published: 2017

Journal Articles

The Effects of Aging on Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease

Craig D. Seaman, MD, Margaret V. Ragni, MD

Blood (2016) 128 (22): 2584.

https://doi.org/10.1182/blood.V128.22.2584.2584

Published: 2016

Journal Articles

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Kristen M Scheitler, Post-Sophomore Fellow, Emily A Coberly, MD, A. Mosharraf Hossain, MD, Richard D Hammer, MD

Blood (2016) 128 (22): 4989.

https://doi.org/10.1182/blood.V128.22.4989.4989

Published: 2016

Journal Articles

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Michelle Lavin, MB FRCPath, Sonia Aguila, PhD, Sonja Schneppenheim, MD, Niall Dalton, BSc, Jamie M O'Sullivan, PhD, Niamh M O'Connell, MB, FRCPath, PhD, Kevin M. Ryan, MB, Mary Byrne, MSc, Margaret Nolan, BSc, Roger Preston, PhD, Ulrich Budde, MD, Paula D. James, MD, Jorge Di Paola, MD, James S O'Donnell, MD PhD

Blood (2016) 128 (22): 873.

https://doi.org/10.1182/blood.V128.22.873.873

Published: 2016

Journal Articles

Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program

Sandra L Haberichter, PhD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Kenneth D Friedman, MD, Robert R. Montgomery, MD

Blood (2016) 128 (22): 874.

https://doi.org/10.1182/blood.V128.22.874.874

Published: 2016

Journal Articles

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Natasha Amrita Satkunam, MBBS, MSc, Johnny Mahlangu, MD, Christoph Bidlingmaier, MD PD, Dr. MD, Maria Eva Mingot-Castellano, PhD, Meera B. Chitlur, MD, Patrick F. Fogarty, MD, Adam Cuker, MD MS, Maria Elisa Mancuso, MD PhD, Pal André Holme, PhD MD, Julie Grabell, BA, CCRP, Wilma Hopman, MA, Prasad Mathew, MD, Paula D. James, MD

Blood (2016) 128 (22): 875.

https://doi.org/10.1182/blood.V128.22.875.875

Published: 2016

Journal Articles

Prevalence of Discrepancy Between the Results of One-Stage and Chromogenic Factor VIII:C Assays in Iranian Patients with Mild / Moderate Hemophilia A

Minoo Ahmadinejad, MD, Fatemeh Vossough, Kataioon Karimi, MD, Mohammad Reza Tabatabaei, Sanaz Homayoun, Mehran Karimi, MD, Gholamreza Toogeh, MD

Blood (2016) 128 (22): 4982.

https://doi.org/10.1182/blood.V128.22.4982.4982

Published: 2016

Journal Articles

Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5′ splice site

Hamideh Yadegari, Arijit Biswas, Mohammad Suhail Akhter, Julia Driesen, Vytautas Ivaskevicius, Natascha Marquardt, Johannes Oldenburg

Blood (2016) 128 (17): 2144–2152.

https://doi.org/10.1182/blood-2016-02-699686

Published: 2016

Includes: Supplemental data

Journal Articles

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Pamela A Christopherson, Veronica H Flood, MD, Sandra L Haberichter, PhD, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Joan Cox Gill, MD, Rupa A Udani, PhD, Robert R Montgomery, MD

Blood (2015) 126 (23): 758.

https://doi.org/10.1182/blood.V126.23.758.758

Published: 2015

Journal Articles

Molecular Basis of Von Willebrand Disease in Patients from India

Sumitha Elayaperumal, M.Sc, Eunice Sindhuvi Edison, PhD, Sankari Devi Govindanattar, B.Sc, Surendar Singh, B.Sc, Aby Abraham, MD DM, Biju George, DM, Auro Viswabandya, MD DM, Sukesh Nair, MD FRCPA, Alok Srivastava, MD FRACP

Blood (2015) 126 (23): 1102.

https://doi.org/10.1182/blood.V126.23.1102.1102

Published: 2015

Journal Articles

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Joan Cox Gill, MD, Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Sandra L Haberichter, PhD, Rupa A Udani, PhD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 2829.

https://doi.org/10.1182/blood.V124.21.2829.2829

Published: 2014

Journal Articles

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Ashley Cartwright, PhD, Pamela A Christopherson, Crystal L. Perry, Sandra L Haberichter, PhD, Daniel Hampshire, PhD, Ian R. Peake, PhD, Anne Goodeve, PhD, Robert R Montgomery, MD, Daniel B. Bellissimo, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1525.

https://doi.org/10.1182/blood.V124.21.1525.1525

Published: 2014

Journal Articles

Validation Study Of The Composite Score To Identify Von Willebrand Disease in Children

Lynn M. Malec, MD, Charity G. Moore, MSPH, PhD, Carolyn M. Bennett, MD, MS, Donald L Yee, MD, Bryce A. Kerlin, MD, Char Witmer, MD, Sriya Gunawardena, MD, Roshni Kulkarni, MD, Sweta Gupta, MBBS, MD, Peter A. Kouides, MD, Deborah Brown, Heather L. Bujnicki, MD, Margaret V. Ragni, MD, MPH

Blood (2013) 122 (21): 2356.

https://doi.org/10.1182/blood.V122.21.2356.2356

Published: 2013

Journal Articles

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Sandra L. Haberichter, Pamela A. Christopherson, Veronica H. Flood, MD, Joan Cox Gill, MD, Daniel B. Bellissimo, Kenneth D Friedman, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 331.

https://doi.org/10.1182/blood.V122.21.331.331

Published: 2013

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

VWF and FVIII Levels after Desmopressin Are Associated with the Bleeding Phenotype in Type 1 VWD

Association of Obesity on Laboratory Profiles of Individuals with Type 1 Von Willebrand Disease and Low VWF in the Athn Dataset

Practice Patterns for Diagnosis of Type 1 Von Willebrand Disease and Effect of Age on Von Willebrand Factor Levels: A Single Institutional Retrospective Study

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Feasibility of a Smartphone Application (App) Pictorial Blood Assessment Chart (PBAC) As an Endpoint in a Von Willebrand Disease Trial

Differentiation of Patients with Type 1 Von Willebrand Disease Vs. Low Normal Levels of the Von Willebrand Factor Using a Very High Shear Rate, Non-Citrated Blood Flow System

The Effects of Aging on Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease

Superimposed Hypercoagulable and Hypocoagulable States: Elevated Von Willebrand Factor (vWF) Levels Secondary to Polycystic Ovary Syndrome Masking Von Willebrand Disease

Novel Insights into the Clinical Phenotype and Pathophysiology Underlying Low VWF Levels: The Low Von Willebrand Factor in Ireland Cohort (LoVIC) Study

Von Willebrand Factor (VWF) Propeptide and Factor VIII (FVIII) Levels Identify the Contribution of Decreased Synthesis and/or Increased Clearance Mechanisms in the Pathogenesis of Type 1 Von Willebrand Disease (VWD) in the Zimmerman Program

Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls

Prevalence of Discrepancy Between the Results of One-Stage and Chromogenic Factor VIII:C Assays in Iranian Patients with Mild / Moderate Hemophilia A

Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5′ splice site

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Molecular Basis of Von Willebrand Disease in Patients from India

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Validation Study Of The Composite Score To Identify Von Willebrand Disease in Children

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only